Walleye Capital LLC Laboratory Corp Of America Holdings Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$209.01 - $232.56 $9.35 Million - $10.4 Million	44,746 New	44,746 $9.78 Million
Q3 2023 Nov 14, 2023	BUY	$201.05 - $221.7 $225,176 - $248,304	1,120 Added 40.58%	3,880 $780,000
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $584,926 - $666,070	2,760 New	2,760 $666,000
Q2 2022 Aug 08, 2022	SELL	$213.86 - $277.87 $623,615 - $810,268	-2,916 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $757,635 - $869,492	2,916 New	2,916 $769,000
Q4 2019 Feb 14, 2020	SELL	$163.48 - $173.61 $6,539 - $6,944	-40 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $6,390 - $7,124	40 New	40 $7,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.